Susquehanna International Group
SBBP

Susquehanna International Group’s Strongbridge Biopharma plc. SBBP Stock Holding History

Susquehanna International Group’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-155,457
Closed -$317K – 14509
2021
Q3 		$317K Buy
155,457
+117,568
+310% +$274K ﹤0.01% 10482
2021
Q2 		$113K Sell
37,889
-9,887
-21% -$26.1K ﹤0.01% 12032
2021
Q1 		$132K Buy
47,776
+29,901
+167% +$90.2K ﹤0.01% 11725
2020
Q4 		$43K Buy
17,875
+4,484
+33% +$10.8K ﹤0.01% 10784
2020
Q3 		$28K Buy
+13,391
New +$45.1K ﹤0.01% 10343
2020
Q2 		– Sell
-10,223
Closed -$30.6K – 11310
2020
Q1 		$19K Sell
10,223
-5,095
-33% -$13.2K ﹤0.01% 9948
2019
Q4 		$32K Sell
15,318
-2,921
-16% -$5.6K ﹤0.01% 9430
2019
Q3 		$44K Sell
18,239
-64,988
-78% -$175K ﹤0.01% 9815
2019
Q2 		$261K Buy
+83,227
New +$306K ﹤0.01% 8595
2018
Q3 		– Sell
-82,924
Closed -$498K – 10604
2018
Q2 		$498K Buy
+82,924
New +$607K ﹤0.01% 6796

Susquehanna International Group's SBBP Position: Q4 2021 in Review

Susquehanna International Group sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 155,457 shares — an estimated $317K sold.

Susquehanna International Group first reported a position in SBBP in Q2 2018 and held it in 10 quarters. The position peaked at $498K in Q2 2018. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

  • Susquehanna International Group reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
  • Susquehanna International Group sold 155,457 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $317K.
  • Susquehanna International Group first reported a position in Strongbridge Biopharma plc. in Q2 2018 and held it in 10 quarters.
  • Susquehanna International Group's Strongbridge Biopharma plc. position peaked at $498K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.